findmyKOL
Clinical trialNCT02682511Active, not recruitingPhase 2Interventional

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

SponsorCumberland PharmaceuticalsEnrollment34Autoimmune DiseasesConnective Tissue DiseasesPathologic ProcessesScleroderma, DiffuseScleroderma, LimitedScleroderma, Systemic+2 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

India
  • Pgimer

    Chandigarh, Chandigarh, India

  • Kdh - Kokilaben Dhirubhai Ambani Hospital

    Mumbai, Maharashtra, India

  • B. J. Government Medical College

    Pune, Maharashtra, India

United States
  • the Universtity of Arizona Arthrtis Center

    Tucson, Arizona, United States

  • Ucla

    Los Angeles, California, United States

  • Cleveland Clinic - Florida

    Weston, Florida, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • University of Nebraska Medical Center

    Omaha, Nebraska, United States

  • Hospital for Special Surgery

    New York, New York, United States

  • Thomas Jefferson University

    Philadelphia, Pennsylvania, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • Baylor Research Institute

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2017
Primary completion
30 Jun 2026
Completion
31 Aug 2026
Last update posted
15 Apr 2026
Registered enrollment
34
Registry id
NCT02682511

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.